Josamycin
Thông số
16846-24-5Số CAS
240-871-6Số EC
[(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxaTên IUPAC
C42H69NO15Công thức hóa học
828 g/molKhối lượng phân tử
josamycin; Leucomycin A3; Turimycin A5; Kitasamycin A3; 16846-24-5; Josamycine; Josamicina; Antibiotic yl-704 A3; Josamycinum; iosalide; josamina; EN-141; Jomybel; Yl-704 A3; Leucomycin V 3-acetate 4b-(3-methylbutanoate); Leucomycin V, 3-acetate 4B-(3-methylbutanoate); HV13HFS217; EN 141; CHEBI:31739; [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate; DTXCID103183; EN141; ((2S,3S,4R,6S)-6-((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl)oxy-4-hydroxy-2,4-dimethyloxan-3-yl) 3-methylbutanoate; ((2S,3S,4R,6S)-6-((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-dimethylamino-5-hydroxy-2-methyloxan-3-yl)oxy-4-hydroxy-2,4-dimethyloxan-3-yl) 3-methylbutanoate; (2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl)oxy)-4-hydroxy-2,4-dimethyloxan-3-yl 3-methylbutanoate; (2S,3S,4R,6S)-6-{[(2R,3S,4R,5R,6S)-6-{[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy}-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy}-4-hydroxy-2,4-dimethyloxan-3-yl 3-methylbutanoate; [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-dimethylamino-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate; josamycin proprionate; RefChem:150573; J01FA07; (2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-10-hydroxy-5-methoxy-9, 16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11, 13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl)oxy)-4-hydroxy-2, 4-dimethyloxan-3-yl 3-methylbutanoate; (3R,4S,5S,6R,8R,9R,10E,12E,15R)-3-Acetoxy-5-(2,6-dideoxy-4-O-(3-methylbutanoyl)-3-C-methyl-alpha-L-ribo-hexopyranosyl-(1->4)-3,6-dideoxy-3-dimethylamino-beta-D-glucopyranosyloxy)-6-formylmethyl-9-hydroxy-4-methoxy-8-methylhexadeca-10,12-dien-15-olide; 240-871-6; DTXSID8023183; Josamycine [INN-French]; Josamycinum [INN-Latin]; Josamicina [INN-Spanish]; Josacine; MFCD00210320; Leucomycin V, 3-acetate 4(sup B)-(3-methylbutanoate); Leucomycin V, 3-acetate 4(sup beta)-(3-methylbutanoate); JM; C42H69NO15; ST075007; Leucomycin A3 (>90%); (2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetoxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2,4-dimethyltetrahydro-2H-pyran-3-yl 3-methylbutanoate; [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetoxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyl-tetrahydropyran-3-yl]oxy-4-hydroxy-2,4-dimethyl-tetrahydropyran-3-yl] 3-methylbutanoate; EINECS 240-871-6; UNII-HV13HFS217; CCRIS 8511; NSC122223; Josamycin CRS; Josamycin [USAN:INN:BAN:JAN]; (2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-Acetoxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-6-yl)oxy)-4-(dimethylamino)-5-hydroxy-2-methyltetrahydro-2H-pyran-3-yl)oxy)-4-hydroxy-2,4-; Josamycin; (4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-(acetyloxy)-6-[[3,6-dideoxy-4-O-[2,6-dideoxy-3-C-methyl-4-O-(3-methylbutanoyl)-a-l-ribo-hexopyranosyl]-3-(dimethylamino)-ss-d-glucopyranosyl]oxy]-10-hydroxy-5-methoxy-9,16-dimethyl-7-(2-oxoethyl)oxacyclohexadeca-11,13-dien-2-one; Josamycin (Standard); JOSAMYCIN [INN]; JOSAMYCIN [JAN]; JOSAMYCIN [MI]; JOSAMYCIN [USAN]; JOSAMYCIN [MART.]; JOSAMYCIN [WHO-DD]; Stereoisomer of 4-(acetyloxy)-6-((3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-4-O-(3-methyl-1-oxobutyl)-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranosyl)oxy)-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-diene-7-acetaldehyde; Stereoisomer of 7-(formylmethyl)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-6-yl 3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranoside 4'-acetate 4''-isovalerate; SCHEMBL132829; Leucomycin V 3-acetate 4(beta)-(3-methylbutanoate); CHEMBL224436; orb1220525; orb1300028; orb3025426; Josamycin (JP18/USAN/INN); JOSAMYCIN [EP MONOGRAPH]; GTPL12924; HY-B1920R; MSK7809; Josamycin, >=98.0% (UV); HY-B1920; MSK7809-100M; s4421; Josamycin 10 |Ig/mL in Acetonitrile; Josamycin for peak identification CRS; MSK7809-1000M; AL24876; DB01321; Josamycin 10 microg/mL in Acetonitrile; Stereoisomer of 7-(formylmethyl)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-6-yl 3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranoside 4'-acetate 4'-isovalerate; Josamycin 1000 microg/mL in Acetonitrile; Josamycin Solution in Methanol, 100ug/mL; Josamycin Solution in Methanol, 1000ug/mL; CS-0013975; Josamycin; Josamycin Propionate EP Impurity E; D01235; D81953; F840980; leucomycin V 3-acetate 4(B)-(3-methylbutanoate); leucomycin V 3-acetate 4beta-(3-methylbutanoate); Q423369; SR-01000883731; EN-141;Kitasamycin A3;Leucomycin A3;Turimycin A5; SR-01000883731-1; Leucomycin V 3-acetate 4(sup B)-(3-methylbutanoate); Josamycin, European Pharmacopoeia (EP) Reference Standard; LEUCOMYCIN V, 3-ACETATE 4(SUP .BETA.)-(3-METHYLBUTANOATE); hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate; Josamycin for peak identification, European Pharmacopoeia (EP) Reference Standard; [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-; 56689-45-3; 6-{6-[(1S,13S,2R,3R,7R,14R,16R)-3-acetyloxy-13-hydroxy-2-methoxy-7,14-dimethyl -5-oxo-16-(2-oxoethyl)-6-oxacyclohexadeca-9,11-dienyloxy](3S,2R,4R,5R,6R)-4-(d imethylamino)-5-hydroxy-2-methyl(2H-3,4,5,; 6-{6-[3-Acetyloxy-13-hydroxy-2-methoxy-7,14-dimethyl-6-oxa-5-oxo-16-(2-oxoethyl)cyclohexadeca-9,11-dienyloxy]-4-(dimethylamino)-5-hydroxy-2-methylperhydro-2H-pyran-3-yloxy}-4-hydroxy-2,4-dimethylperhydro-2H-pyran-3-yl 3-methylbutanoate; 6-tetrahydropyran-3-yloxy)}(2S,3S,4R ,6R)-4-hydroxy-2,4-dimethyl-2H-3,4,5,6-tetrahydropyran-3-yl 3-methylbutanoateTên gọi khác
